PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.26%
Negative revenue growth while NXPI stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-26.53%
Negative gross profit growth while NXPI is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
22.34%
EBIT growth of 22.34% while NXPI is zero. Bruce Berkowitz would see if small gains can be scaled further.
-80.00%
Negative operating income growth while NXPI is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-84.11%
Negative net income growth while NXPI stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-88.89%
Negative EPS growth while NXPI is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-88.89%
Negative diluted EPS growth while NXPI is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.47%
Share reduction while NXPI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.62%
Reduced diluted shares while NXPI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.47%
Dividend growth of 0.47% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-77.55%
Negative OCF growth while NXPI is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-80.02%
Negative FCF growth while NXPI is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
28.28%
10Y CAGR of 28.28% while NXPI is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-3.43%
Negative 5Y CAGR while NXPI stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-22.22%
Negative 3Y CAGR while NXPI stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
45.03%
OCF/share CAGR of 45.03% while NXPI is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-13.19%
Negative 5Y OCF/share CAGR while NXPI is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-43.98%
Negative 3Y OCF/share CAGR while NXPI stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-91.64%
Negative 10Y net income/share CAGR while NXPI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-93.70%
Negative 5Y net income/share CAGR while NXPI is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-96.39%
Negative 3Y CAGR while NXPI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
72.90%
Equity/share CAGR of 72.90% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
3.59%
Equity/share CAGR of 3.59% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
1.88%
Equity/share CAGR of 1.88% while NXPI is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
435.74%
Dividend/share CAGR of 435.74% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
417.97%
Dividend/share CAGR of 417.97% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
265.17%
3Y dividend/share CAGR of 265.17% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
23.22%
AR growth of 23.22% while NXPI is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-20.15%
Inventory is declining while NXPI stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.38%
Negative asset growth while NXPI invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.78%
We have a declining book value while NXPI shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-10.44%
Our R&D shrinks while NXPI invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-15.75%
We cut SG&A while NXPI invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.